Press Releases

The research is focused on the development of novel splice-switching antisense oligonucleotides (ASOs) for one of the most common CFTR variants in people of African heritage. Lower Merion, PA – November 20, 2023 — Emily’s Entourage (EE), an innovative 501(c)3 that accelerates research for new treatments and a cure for the final 10% of people with cystic fibrosis (CF), today announced it... Read More

The research is focused on developing polymeric vehicles to improve the delivery of  nucleic acid-based therapeutics to target tissues and cells in the body for the treatment of CF.   Lower Merion, PA – November 20, 2023 — Emily’s Entourage (EE), an innovative 501(c)3 that accelerates research for new treatments and a cure for the final 10% of people with cystic fibrosis (CF),... Read More

The research is focused on developing partially humanized mouse airways to be utilized for testing the efficiency of gene delivery methods, including AAV vectors and lipid nanoparticles. Lower Merion, PA – November 20, 2023 — Emily’s Entourage (EE), an innovative 501(c)3 that accelerates research for new treatments and a cure for the final 10% of people with cystic fibrosis (CF), today announced... Read More

The research is focused on the identification and validation of new or improved therapeutic approaches for nonsense mutations of cystic fibrosis (CF) Lower Merion, PA – February 1, 2023 — Emily’s Entourage (EE), an innovative 501(c)3 foundation that accelerates research for new treatments and a cure for the final 10% of people with cystic fibrosis (CF), including those with nonsense mutations, today... Read More